Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

Walmart steel cage match (although we would totally watch). Instead, Walmart gave its logo a makeover fit for modern times—at least that was the idea. But people, well, they have feelings.

Walmart announced on Monday that it had unveiled a new logo, part of "a comprehensive brand refresh." The U.S.-based retailer boasted in a news release that the new look — its first change ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The company’s shares closed yesterday at $51.57.

Here are some before and after pictures of the company's wordmark and logo. Need a break? Play the USA TODAY Daily Crossword Puzzle. Here's a look at how the new wordmark and logo will appear on ...

For the first time in almost 20 years, Walmart has a new logo. The international retailer describes it as a “a comprehensive brand refresh,” but the online world hasn’t been quite so kind to ...

Walmart is giving its logo the first facelift in nearly two decades, rolling out a new identity that is a subtle nod to its past. The 61-year-old company unveiled Monday a refresh of its brand ...

It’s January, which means your Instagram feed, your favorite podcast, and every storefront you pass is brimming with ideas for New Year’s goals and intentions. You’re all for hitting the ...

CVS Health stock has badly underperformed the market over the past few years. Rising costs and uncertainty has led the company to reduce guidance multiple times. The healthcare giant is reportedly ...

CVS announced CostVantage in late 2023 as its pharmacies struggled with flatlining payment for dispensing drugs. The company blamed an antiquated reimbursement model that led pharmacies to use ...

CVS announced CostVantage in late 2023 as its pharmacies struggled with flatlining payment for dispensing drugs. The company blamed an antiquated reimbursement model that led pharmacies to use higher ...

Allen Lutz, an analyst from Bank of America Securities, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target remains the same with $63.00. Discover ...